The Myeloma Institute for Research and Therapy is the largest and most comprehensive program in the world for the treatment of and research in multiple myeloma and related disorders.  Noted for its novel translational research, the Myeloma Institute continually pursues progress in the basic laboratory that can be applied to development of curative therapies. Patients come to the Myeloma Institute from every state in the U.S. and from over 40 countries around the globe.

Myeloma Institute researchers have a history of successfully securing grant funding.  However, donor funding comprises 33% of the Institute’s annual budget, and the majority of that 33% is channeled into research.  Primary areas of research are related to

• Investigating the molecular genetic signature of myeloma with the goal of customizing treatment based on individual risk factors
• Understanding the role of the bone marrow microenvironment in disease progression with the goal of developing treatments that target both the microenvironment and the disease itself
• Developing immunotherapy interventions that enable the body to fight off the myeloma

Treatments tested at the Myeloma Institute through clinical trials are adopted by major cancer centers.  We are clearly setting the standard.  We depend on donations for research to enable us to continue on our established course of excellence.